13F Holdings
中文EN

KBLB Kraig Biocraft Laboratories, Inc.

Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) · OTC · SEC CIK 1413119 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-5.3%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-127.4%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets300.7%
Debt / equity—
Current ratio0.27x
Interest coverage-5.67x

Cash quality & payout

Operating cash flow / net income0.56x
Accruals ratio-56.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue—————
R&D expense$165,758$164,374$237,871$176,431$197,745
SG&A expense$1.96M$1.75M$1.45M$825,460$1.50M
Operating income-$3.37M-$3.07M-$2.61M-$2.12M-$2.76M
Interest expense$570,709$529,603$484,658$153,955$238,110
Pretax income-$3.62M-$3.40M-$3.03M-$3.84M-$8.05M
Net income-$3.62M-$3.40M-$3.03M-$3.84M-$8.05M
EBITDA-$3.35M-$3.05M-$2.59M-$2.09M-$2.73M
EPS (basic)0.000.000.000.00-0.01
EPS (diluted)0.000.000.000.00-0.01
Weighted avg. shares (diluted)1.06B1.04B1.03B974.31M877.61M
Balance sheet
Cash & equivalents$1.79M$673,264$2.55M$3.86M$2.36M
Short-term investments$0$0$0——
Inventory$29,067$6,884$6,884$6,580—
Current assets$1.87M$740,285$2.57M$3.98M$2.37M
PP&E, net$25,003$44,721$66,640$87,861$110,943
Total assets$2.57M$1.51M$3.23M$4.57M$3.02M
Current liabilities$10.45M$9.61M$8.89M$8.07M$8.16M
Total liabilities$10.56M$9.65M$8.94M$8.09M$8.32M
Shareholders' equity-$8.00M-$8.15M-$5.71M-$3.52M-$5.30M
Cash flow statement
Operating cash flow-$1.79M-$1.84M-$1.24M-$1.89M-$1.80M
Capital expenditure$5,395$4,240$6,399$5,021$97,154
Free cash flow-$1.79M-$1.84M-$1.25M-$1.89M-$1.90M
Investing cash flow$438,042-$4,240-$6,399-$5,021-$547,370
Financing cash flow$2.47M-$35,244-$60,000$3.40M$3.89M
Depreciation & amortization$25,113$26,159$27,620$28,103$26,137
Stock-based compensation$87,285————

Free plan shows the latest 5 periods; Pro shows all 19 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.